In 2023, Italy's import of blood-grouping reagents stood at approximately 27.8 million USD. The forecast from 2024 to 2028 shows a steady increase, growing from 28.198 million USD in 2024 to 29.901 million USD by 2028. Year-on-year growth is expected to hover just above 1.5%, indicative of moderate growth within this sector. The compound annual growth rate (CAGR) over this five-year forecast period is projected at an average of 1.8% annually.
Future trends to watch for include advancements in medical technology, changes in healthcare regulations, and shifts in demand due to evolving healthcare needs. Monitoring these factors will be crucial for stakeholders within the blood-grouping reagent industry to adjust strategies effectively.
